SecBot SecBot
8-K ·Filed May 19, 2026

HIMS

Hims & Hers Health, Inc.
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0001193125-26-229749
8-K context-dependent: Items 8.01
Actionable Insight ◆ Mixed

Monitor for closing of Eucalyptus acquisition (target mid-2026) and subsequent execution on international expansion. The zero-coupon structure and capped call mitigate near-term dilution, but the added leverage and potential share conversion over time warrant attention to EBITDA coverage.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
HIMS ▲ +28.21% at T+60d
NEUTRAL call +28.21% · α vs SPY +21.92% · entry $22.44 → $28.77
Entry = T+0 close
May 19, 2026
via day close
T+1d
+2.67%
call +2.67% · α +1.63%
$23.04
settled 5mo ago
T+5d
+11.54%
call +11.54% · α +9.30%
$25.03
settled 5mo ago
T+20d
+42.11%
call +42.11% · α +41.13%
$31.89
settled 4mo ago
T+60d
+28.21%
call +28.21% · α +21.92%
$28.77
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Hims & Hers upsized its zero-coupon convertible senior notes offering to $350M (from $300M) to fund its international expansion, including the proposed acquisition of Eucalyptus, and AI platform investments. The notes are convertible at ~$29.53 per share (32.5% premium) and include capped call provisions to limit dilution. Net proceeds are estimated at ~$338.5M, with ~$32M used for capped call costs.

Key Facts

  • $350M aggregate principal amount of 0.00% convertible senior notes due 2032, upsized from $300M
  • Initial conversion price ~$29.53 per share, representing a ~32.5% premium over the $22.29 closing price
  • Net proceeds estimated at ~$338.5M (~$389.5M if greenshoe fully exercised)
  • Proceeds intended for Eucalyptus acquisition (expected mid-2026), technology/fulfillment infrastructure, and AI investment
  • Capped call transactions entered with cap price ~$50.15 per share to limit dilution

Financial Impact

Offering size ~6.7% of $5.2B market cap; zero-coupon debt with maturity 2032; dilution limited by capped call

dilutiondebtcash

Risk Factors

  • Dilution if stock appreciates above conversion price (~$29.53) and holders convert
  • Execution risk on Eucalyptus integration and international expansion
  • Increased leverage despite zero-coupon terms

Market Snapshot

Exchange
NYSE
Sector
Services-Offices & Clinics of Doctors of Medicine
Analyst Consensus
43% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-229749
Document: d227898dex992.htm0001193125-26-229749
Document: d227898dex991.htm0001193125-26-229749
Document: 0001193125-26-229749-index-headers.html0001193125-26-229749
Document: 0001193125-26-229749-index.html0001193125-26-229749
Document: 0001193125-26-229749.txt0001193125-26-229749
19 reports for HIMS
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 4 of 5 best @ T+20▲ +36.57%Jun 2, 2026
Filters
Rows
Reports for HIMS — sortable, filterable
TypeNow
Oct 27, 2026
today
Institutional Cluster
NEUTRAL ★ 2/10
$28.18awaiting T+20—$27.92 (−0.92%)
Oct 7, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$28.06awaiting T+20—$27.92 (−0.50%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 5/10
$29.28 $29.13▲ +0.51%▲ +0.09%$27.92 (+4.64%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$29.35 $28.15▲ +4.09%▲ +3.18%$27.92 (+4.87%)
Sep 17, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$27.99 $28.07▼ −0.29%▼ −0.08%$27.92 (+0.25%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.92 (−17.35%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.78 $29.35▼ −13.11%▼ −14.13%$27.92 (−17.35%)
Aug 18, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.09 $27.89▼ −10.29%▼ −9.45%$27.92 (−10.20%)
Aug 10, 2026
11w ago
8-K
MIXED ★ 7/10
$30.51 $27.90▼ −8.55%▼ −7.50%$27.92 (−8.49%)
Jul 1, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$36.80 $27.04▼ −26.52%▼ −26.11%$27.92 (−24.13%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 19, 2026